DLIF & XLIF Implants Market Report Overview
-
Request a Free Sample to learn more about this report
The global DLIF & XLIF implants market size was USD 213.6 million in 2022 and is expected to reach USD 320.22 million in 2031, exhibiting a CAGR of 4.6% during the forecast period.
DLIF (Direct Lateral Interbody Fusion) and XLIF (Extreme Lateral Interbody Fusion) are surgical techniques used to treat spinal conditions by fusing vertebrae together. Both procedures involve accessing the spine from a lateral (side) approach rather than traditional anterior (front) or posterior (back) approaches. Here's an explanation of DLIF and XLIF implants. DLIF is a minimally invasive surgical technique that allows access to the intervertebral disc space and the removal of damaged disc material through a lateral approach. In DLIF, a small incision is made on the patient's side, and specialized instruments are used to reach the affected disc space.
COVID-19 Impact: Pandemic Hamper the Demand of DLIF & XLIF implants to Market Growth
The global Covid-19 pandemic has been unprecedented and staggering, with the DLIF & XLIF implants market experiencing higher than anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
The COVID-19 pandemic has had a significant impact on various aspects of healthcare, including surgical procedures like DLIF and XLIF. During the height of the pandemic, many hospitals and healthcare facilities faced resource constraints and prioritized urgent and emergency cases. As a result, elective surgeries, including DLIF and XLIF procedures, were often delayed or postponed to conserve resources, reduce the risk of exposure to the virus, and prioritize COVID-19 patients. This led to a backlog of cases and increased waiting times for patients.
Latest Trends
"DLIF & XLIF Implants Will Drive Market Growth "
Robotic navigation systems have been developed specifically for spine surgeries, including DLIF and XLIF procedures. These systems utilize pre-operative imaging data to create a 3D map of the patient's spine. Surgeons can then use robotic instruments to navigate and precisely place implants during the surgery. Robotic guidance enhances accuracy, reduces the risk of complications, and allows for more targeted and controlled implant placement.
DLIF & XLIF Implants Market Segmentation
-
Request a Free Sample to learn more about this report
- By Type Analysis
According to type, the DLIF & XLIF implants market can be segmented into DLIF implants and XLIF implants.
In terms of type, DLIF implants is anticipated to be the largest segment during the forecast period.
- By Application Analysis
Based on application, the DLIF & XLIF implants market can be scoliosis, degenerative disc diseases and spondylolisthesis.
In terms of application, the scoliosis market is projected to hold a DLIF & XLIF implants market share through 2028.
Driving Factors
"Enhanced Surgical Precision and Accuracy Will Boost Market Growth "
Robotic-assisted surgery offers improved precision and accuracy compared to traditional manual techniques. The ability of robotic systems to navigate through complex anatomical structures with high precision reduces the risk of human error. Surgeons can achieve more accurate tissue dissection, implant placement, and fusion, leading to better surgical outcomes and patient satisfaction.
"Minimization of Surgical Trauma Will Fuel Market Growth "
Robotic-assisted surgery allows for minimally invasive approaches, reducing surgical trauma compared to open procedures. Smaller incisions, reduced tissue damage, and minimized blood loss contribute to faster recovery, decreased post-operative pain, and shorter hospital stays. Patients can experience improved overall surgical outcomes and quicker return to normal activities.
Restraining Factors
"Cost and Financial Considerations Will Limit Market Growth "
Robotic-assisted surgery systems often come with significant upfront costs, including the purchase or lease of robotic platforms, instruments, and associated equipment. Additionally, there are ongoing maintenance and servicing expenses. These financial considerations can be a restraining factor for some healthcare institutions, especially smaller hospitals or those with limited budgets. The cost-effectiveness of robotic-assisted surgery compared to traditional techniques is an important consideration that may impact adoption.
DLIF & XLIF Implants Market Regional Insights
-
Request a Free Sample to learn more about this report
"The North America Region will Dominate Market Due to Strong Demand of Robotic Technologies"
North America, particularly the United States, has been at the forefront of adopting robotic-assisted surgery across various specialties. The region has well-established healthcare infrastructure, advanced surgical centers, and a favorable reimbursement environment. Major medical device companies have introduced robotic systems for spine surgeries, including DLIF and XLIF procedures, in this region. Surgeons in North America often have access to the latest robotic technologies and are more likely to adopt them due to the availability of resources and supportive regulatory frameworks.
Europe has shown significant interest in robotic-assisted surgery, including spine procedures. Several European countries have witnessed the implementation of robotic systems in specialized spine centers and larger hospitals. However, the adoption may vary across different European regions due to differences in healthcare systems and reimbursement policies. Some countries may face budgetary constraints or regulatory challenges that impact the widespread adoption of robotic-assisted surgery. Nevertheless, Europe remains an active region for the development and utilization of robotic technologies in spine surgery.
Key Industry Players
"Adoption Recycling Services by Key Players Influencing Market Development"
The top key players in the DLIF & XLIF implants market are Medtronic, NuVasive, Globus Medical, Stryker, Johnson & Johnson (DePuy Synthes). Most of the top players hold the DLIF & XLIF implants market share. In addition, the strategies to develop new technologies, capital investment in R&D, improve product quality, acquisitions, mergers, and compete for the DLIF & XLIF implants market growth in the competition help them to perpetuate their position and value in the market. Besides, collaboration with other companies & extensive possession of market shares by the key players stimulates the DLIF & XLIF implants market.
List of Market Players Profiled
- Medtronic (Ireland)
- NuVasive (U.S.)
- Globus Medical (U.S.)
- Stryker (U.S.)
- Johnson & Johnson (DePuy Synthes) (U.S.)
- Orthofix (U.S.)
- Zimmer Biomet (U.S.)
Report Coverage
This report examines an understanding of the DLIF & XLIF implants market’s size, share, growth rate, segmentation by type, application, key players, and previous and current market scenarios. The report also collects the market’s precise data and forecasts by market experts. Also, it describes the study of this industry’s financial performance, investments, growth, innovation marks, and new product launches by the top companies and offers deep insights into the current market structure, competitive analysis based on key players, key driving forces, and restraints that affect the demand for growth, opportunities, and risks.
Furthermore, the post-COVID-19 pandemic’s effects on international market restrictions and a deep understanding of how the industry will recover, and strategies are also stated in the report. The competitive landscape has also been examined in detail to provide clarification of the competitive landscape.
This report also discloses the research based on methodologies that define price trend analysis of target companies, collection of data, statistics, target competitors, import-export, information, and previous years’ records based on market sales. Moreover, all the significant factors which influence the market such as small or medium business industry, macro-economic indicators, value chain analysis, and demand-side dynamics, with all the major business players have been explained in detail. This analysis is subject to modification if the key players and feasible analysis of market dynamics change.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 213.6 Million in 2022 |
Market Size Value By |
US$ 320.22 Million by 2031 |
Growth Rate |
CAGR of 4.6% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the global DLIF & XLIF implants market expected to touch by 2031?
The global DLIF & XLIF implants market is expected to reach USD 320.22 million by 2031.
-
What CAGR is the DLIF & XLIF implants market expected to exhibit during 2024-2031?
The DLIF & XLIF implants market is expected to exhibit a CAGR of 4.6% over 2024-2031.
-
Which are the driving factors of the DLIF & XLIF Implants market?
Enhanced surgical precision and accuracy are the driving factor of the DLIF & XLIF Implants market.
-
Which are the top companies operating in the DLIF & XLIF Implants market?
Medtronic, NuVasive, Globus Medical, Stryker, Johnson & Johnson (DePuy Synthes) are the top operating companies in the DLIF & XLIF Implants market.